Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)

Organon and Co401 enrolled

Overview

The purpose of this study is to evaluate the efficacy of MK0663 for the treatment of chronic low back pain and to investigate the overall safety and tolerability over four weeks of treatment.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

401

Conditions

Chronic Low Back Pain

Interventions

MK0663, etoricoxib / Duration of Treatment: 4 weeksDRUG

Comparator: diclofenac / Duration of Treatment: 4 weeksDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male and female patients 18 years of age or older, who have Chronic Low Back Pain after the discontinuation of their previous medication for their condition. * Patients should have at least 3 months of Low Back Pain.

Outcomes

Primary Outcomes

Lower back pain intensity

Safety and tolerability

Secondary Outcomes

Disability questionnaire

Patient global assessment of response to therapy

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.